Concepedia

Ling Chen

LC

Statistics

Publications

13

Citations

371

H-Index

12

Active since

2017

Affiliations

Fujian Medical University(Current)

First Affiliated Hospital of Fujian Medical University

Central South University

Second Xiangya Hospital of Central South University

Fujian Normal University

Ling Chen is an author at Fujian Medical University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2017–2023

13

Publications

13

TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells

Kunlin Wu, Huihao Zhang, Yajuan Fu et al. · Molecular Medicine Reports · 2018 · 69 citations · Full text

, , +15

<scp>FTO</scp>‐mediated epigenetic upregulation of <scp>LINC01559</scp> confers cell resistance to docetaxel in breast carcinoma by suppressing <scp>miR</scp>‐1343‐3p

Wei Lin, Caiqin Mo, Lingjun Kong et al. · The Kaohsiung Journal of Medical Sciences · 2023 · 38 citations · Full text

, , +17

The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties

Na Liu, Rui Yang, Ling Chen et al. · Signal Transduction and Targeted Therapy · 2020 · 36 citations · Full text

, , +13

ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling

Ling Chen, Jun Tang, Yixiao Feng et al. · Cellular Physiology and Biochemistry · 2017 · 35 citations · Full text

, , +17

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer

Cen Jiang, Youzhi Zhu, Huaying Chen et al. · Cell Death and Disease · 2023 · 31 citations · Full text

, , +17

1–5 of 13